- CloudMD Software & Services Inc. (DOC) has received positive results for its therapist assisted internet-based cognitive behavioural therapy (TAiCBT) study
- Patients started treatment with a depression symptom score in the severe range and finished with moderate depression
- More than half of the patients experienced reliable symptom improvement
- CloudMD stated its treatment is five times faster than public health treatments
- CloudMD Software & Services Inc. (DOC) is up 1.92 per cent trading at $0.53 per share as of 12:21 p.m. ET.
CloudMD Software & Services (DOC) has received positive results for its therapist assisted internet-based cognitive behavioural therapy (TAiCBT) study.
The patients were reported to have started treatment with a depression symptom score in the severe range and finished with moderate depression. CloudMD stated more than half of its patients experienced reliable symptom improvement from the novel treatment.
The company indicated that its treatments proved to be five times faster than the average month-long wait for community health or even longer for people needing extra support for things like post-traumatic stress.
CloudMD’s clinically based TAiCBT provider, MindBeacon, completed the study to understand the effectiveness of its depression protocol for those experiencing symptoms of both depression and anxiety.
The study also inspected the relationship between moderating and mediating factors, such as a person’s characteristics and their interactions with therapists, as well as symptom reduction.
According to CloudMD, the TAiCBT study collected two years’ worth of data made up of 12,839 qualifying people who participated. Roughly 77 per cent of the patients start treatment with what is considered clinical level symptoms of depression, with 56 per cent suffering from both depression and anxiety symptoms.
“Furthermore, we have one of the largest data sets for clinically based TAiCBT outcome measurement and data integrity… along with having the right processes in place to capture the proof points, and provide important outcomes data to our customers,” Karen Adams, President and Interim CEO of CloudMD, said.
CloudMD Software & Services Inc. (DOC) is up 1.92 per cent trading at $0.53 per share as of 12:21 p.m. ET.
